Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
... a novel collaborative research agreement with the
genomics Institute of the Novartis Research Foundation ... and JDRF volunteers.
About GNF
The
genomics Institute of the Novartis Research Foundation ... cut across the life sciences, and include
genomics and proteomics tools, medicinal chemistry, ...
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease
... Sun Health Research Institute, Translational
genomics Research Institute and the University of Arizona. ... .
About TGen
The Translational
genomics Research Institute (TGen) is a Phoenix, ... Sun Health Research Institute, the Translational
genomics Research Institute (TGen) and the University of ...
Advance in Bowel Cancer Test Research
... and Australian healthcare company, Clinical
genomics Pty Ltd - designed to develop an improved ... Professor Young says.
The CEO of Clinical
genomics Pty Ltd, Lawrence La Pointe, says if a more ... 400 995 027
Lawrence La Pointe
Clinical
genomics Pty Ltd
E: larry@clinicalgenomics.com
...
First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
... Malaysia, May 20 /PRNewswire/ -- Synthetic
genomics Inc. (SGI), a privately held company applying ... Asiatic Development Berhad.
About Synthetic
genomics Inc.
SGI, a privately held company founded in ... and environment challenges. Advances in synthetic
genomics present limitless applications in a variety of ...
Clinical Genomics Continues Progress in Developing Biomarker Portfolio for Colorectal Cancer Testing
... SYDNEY, April 29 /PRNewswire/ -- Clinical
genomics Pty Ltd, an Australian
biotechnology company, ... early onset of colorectal cancer. Clinical
genomics was awarded the
payments after successfully ... [1]American Cancer Society
About Clinical
genomics
...
Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
... and diagnostic company, and Rosetta
genomics Ltd. (Nasdaq: ROSG ), an innovative molecular ... strategy for many diseases.
About Rosetta
genomics
Rosetta
genomics is a leading molecular diagnostics company ...
Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
... February 12 /PRNewswire-FirstCall/ --
Rosetta
genomics Ltd. (Nasdaq: ROSG ) reported today the first ... Inc.
About Rosetta
genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leading developer of ...
Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests
... test," noted Dr. Dalia Cohen, Rosetta
genomics Chief
Scientific Office." miRview(TM) squamous is ... samples
had been misclassified.
Rosetta
genomics will host a conference call with a simultaneous ... strategy for many
diseases.
About Rosetta
genomics
...
Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
... studies.
In phase one of the project, Complete
genomics will use its proprietary
DNA sequencing ... Complete Genomics
Founded in 2006, Complete
genomics is a California company that has
developed a novel approach to sequencing human DNA. Complete
genomics plans
to combine its proprietary third-generation ...
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
... Earlier This Year
Rosetta
genomics is Expecting to Launch miRview(TM) Squamous Later ... biomarkers identified by the company, Rosetta
genomics has
developed a test which differentiates ... and
discovery.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ...
Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
... This Proprietary Technology, Rosetta
genomics is Currently Developing a ... many diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies,
Rosetta
genomics is working on the application of these ...
Gene That Causes Childhood Cancer Neuroblastoma Is Found
... analytic equipment at the
Center for Applied
genomics at Children's Hospital. By employing
genome-wide ... the Carly
Hillman Fund. The Center for Applied
genomics at The Children's Hospital of
Philadelphia also ... M.D., Ph.D., director of
the Center for Applied
genomics at Children's Hospital. The above
co-authors are ...
M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
... and who meet the eligibility
criteria. Rosetta
genomics expects this test to be submitted for ... diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies,
Rosetta
genomics is working on the application of these ...
First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
... the first step in the
transformation of Rosetta
genomics into a commercial diagnostics company,"
said Amir ... as other lung cancers at central labs.
Rosetta
genomics expects two additional tests based on its ... diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ...
Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
... Rabin Medical Center, and
Chairman of the Rosetta
genomics Medical Advisory Board. " There is true
unmet ... the globe.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies,
Rosetta
genomics is working on the application of these ...
Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
... Jersey, May 16
/PRNewswire-FirstCall/ -- Rosetta
genomics Ltd. (Nasdaq: ROSG ), a leader in
the development ... implications. In the
present study, Rosetta
genomics and collaborators use microRNAs as
biomarkers for ... diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ...
Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology
... California, Irvine School of Medicine
Rosetta
genomics Expects Three Tests Applying its MicroRNA ...
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies,
Rosetta
genomics is working on the application of these ...
Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
... inhibitor, in the United States.
Rosetta
genomics expects two additional tests based on its ...
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of ... and proprietary platform technologies,
Rosetta
genomics is working on the application of these ...
Gene Hunters Fine-Tune Marker for Common Obesity Gene
... PHILADELPHIA, March 12 /PRNewswire-USNewswire/ --
genomics researchers,
seeking to replicate another group's ... Ph.D., both of the Center for Applied
genomics of The Children's
Hospital of Philadelphia, was ... single nucleotide
polymorphisms, or SNPs.
For
genomics researchers, said Grant, the findings mean that ...
Personalized Medicine - The Genomic Revolution in Cardiac Care
... and implications around the growing forces
of
genomics and personalized medicine in cardiology. This ... the current
status and future directions of the
genomics of atherosclerotic
cardiovascular disease, heart ... agenda features luminaries in the field of
genomics who
will explore the state of ...
Diabetes Gene Raises Odds of Lower Birth Weight
... leader Struan F.A. Grant, Ph.D., a researcher at the Center for Applied
genomics of The Children's Hospital of Philadelphia. "This gene variant carries a ... co-leader Hakon Hakonarson, Ph.D., director of the Center for Applied
genomics at Children's Hospital, investigated 20 gene locations previously reported ...
Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
... pleased to be a part of this research effort because working with Sirius
genomics will help translate genomic biomarker research in sepsis from the lab ... combined.
About Sirius Genomics: www.siriusgenomics.com
Sirius
genomics is a drug-enabling company that develops pharmacogenomic (PGx) diagnostics ...
Autism Genes Discovered; Help Shape Connections Among Brain Cells
... leader Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied
genomics at The Children's Hospital of Philadelphia. He is on the faculty of the ... of specific genes that give rise to cancers. Our extensive pediatric
genomics program has pinpointed particular genes and biological pathways, and this ...
Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
... The study was conducted by SM in collaboration with the Translational
genomics Research Institute's Pharmaceutical
genomics Division in Scottsdale, Arizona.
"This study has identified certain ...
Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project
... to amplify DNA samples for The
Cancer Atlas Genome Project.
Rubicon
genomics was selected to amplify and standardize total genomic
DNA from 3,000 ... or (734) 368-1705.
About IGC
The International
genomics Consortium (IGC) is a non-profit medical
research foundation established ...
MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
... diagnostic strategy for
many diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of microRNA.
Founded in 2000, ... on its strong IP position and proprietary platform technologies,
Rosetta
genomics is working on the application of these technologies in the
development of ...
febit and TGen Collaborate to Study New DNA Capture Method
... HEIDELBERG, Germany, Aug. 14 /PRNewswire/ -- febit
and the Translational
genomics Research Institute (TGen) today announced
the formation of a collaboration ... of
applications.
http://www.febit.com
About TGen
The Translational
genomics Research Institute (TGen) is a non-profit
501(c)(3) organization dedicated ...
Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
... diagnostic strategy
for many diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of microRNA.
Founded in 2000, ... on its strong IP position and proprietary platform technologies,
Rosetta
genomics is working to develop a full range of microRNA-based
diagnostic and ...
Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
... ST. LOUIS, June 11 /PRNewswire/ -- Orion
genomics announced today that
the company entered into a worldwide exclusive ... size of more than 81 million people."
About Orion Genomics
Orion
genomics develops epigenetic research tools and molecular
diagnostic products to ...
Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
... diagnostic strategy for
many diseases.
About Rosetta Genomics
Rosetta
genomics (Nasdaq: ROSG ) is a leader in the field of microRNAs.
Founded in 2000, ... on its strong IP position and proprietary platform technologies,
Rosetta
genomics is working on the application of these technologies in the
development of ...
Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC)
...
genomics improves our ability to target experimental cancer treatments A ... that leads to the development of HCC.
Applying the technologies of
genomics and microarrays, scientists have
discovered that there are a number of ...
Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
... Cancer -
ST. LOUIS, Dec. 20 /PRNewswire/ -- Orion
genomics announced today the
discovery and validation of the most frequent DNA ... programs in cancers of the bladder, breast,
lung, ovaries and colon. Orion
genomics is located in the Center for
Emerging Technologies in St. Louis. For more ...
ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
... the mechanism of
leukocyte replenishment. About TGen The Translational
genomics Research Institute (TGen), a non-profit
501(c)(3) organization, is focused on developing earlier diagnostics and
smarter treatments. Translational
genomics research is a relatively new
field employing innovative advances arising ...
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
... by the Harvard Medical
School-Partners HealthCare Center for Genetics and
genomics (HPCGG). Warfarin (also called Coumadin) is a drug prescribed to help ... of the Harvard Medical School-Partners HealthCare Center for
Genetics and
genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is
coordinating the "CReating ...
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
... is primarily a molecular diagnostics
business that is using proprietary
genomics and proteomics discovery
platforms to identify and validate novel ... developing new diagnostic products outside
of this alliance. Through its
genomics and proteomics research efforts,
Celera is also discovering and validating ...
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
... by the Harvard Medical
School-Partners HealthCare Center for Genetics and
genomics (HPCGG). Warfarin (also called Coumadin) is a drug prescribed to help ... of the Harvard Medical School-Partners HealthCare Center for
Genetics and
genomics (HPCGG) in Cambridge, Massachusetts. HPCGG is
coordinating the "CReating ...
Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
... Because this culture collection holds considerable potential for product innovation, DANONE RESEARCH using state-of-the-art technologies such as
genomics and robotics to select the probiotic bacteria of the future is carefully studying it. For more information, please visit www.danone.com/?lang=en , ...
deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
... of Bonn, the University Medical Center of Utrecht, Nijmegen
Medical Center, the University of Verona, the Duke University Center for
Population
genomics and Pharmacogenetics and the University of Sichuan,
China. Follow up cohorts included those from Aarhus University, the National
Serum Institute, and ...
/C O R R E C T I O N -- Agendia B.V./
... the personalized medicine revolution,
striving to bring more effective, individualized treatment within reach of
patients. Building on a cutting edge
genomics platform for tumor gene
expression profiling, the company's tests aim to help physicians more
accurately tailor cancer therapy. The company markets ...
More Gene Mutations Linked to Autism Risk
... are more likely to directly disrupt biological functions," said study leader Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied
genomics at The Children's Hospital of Philadelphia and associate professor of Pediatrics at the University of Pennsylvania School of Medicine. "We ...